IS INTRADUCTAL HYPERLASIA A RISK FOR BREAST CANCER SUCH AS ATYPICAL HYPERPLASIA AND WHAT IS THE DIFFERENCE?
IS INTRADUCTAL HYPERLASIA A RISK FOR BREAST CANCER SUCH AS ATYPICAL HYPERPLASIA AND WHAT IS THE DIFFERENCE?
Dear BS883: Atypical hyperplasia indicates that there are cells within the ducts that have developed changes inconsistent with normal tissue growth. These are not technically malignant. The concern is that if this were to go unchecked, these cells may develop cancerous changes. The usual progression is thought to be atypical hyperplasia, DCIS, invasive ductal carcinoma. Of course, the length of time it takes for cells to mutate from one thing to another is largely unknown and most likely varies from person to person. Usually, the recommendation might be more frequent mammography (every 6 months). Depending on the individual, the doctor may also recommend avoiding hormone replacement therapy.